SE VOCÊ AINDA NÃO LEVOU AS ROSAS..É SÓ LEVAR..UM GRNADE ABRAÇO.
FIZ COM MUITO CARINHO...

VENHA COMPARTILHAR COMIGO NESTE BLOGS. FAÇA PARTE.

VENHA INTERAGIR COM
ESTE BLOG.
MEUS MIMOS
RECEBIDOS/OFERECIDOS.

SINAL DE LIBERDADE



Wow. The author of Hebrew psychology blog alhasapa has done me the honor of offering to translate one of my posts, Commericalization vs Medicalization, into Hebrew. The translation is up here.
Wow. The author of Hebrew psychology blog alhasapa has done me the honor of offering to translate one of my posts, Commericalization vs Medicalization, into Hebrew. The translation is up here.
An unexpected gem from last year's Journal of the American Psychoanalytic Association: Mind over medicine.Our group at Columbia has completed preliminary work involving metaanalyses of randomized controlled trials comparing antidepressant medications to a placebo or active comparator in geriatric outpatients with Major Depressive Disorder (Sneed et al. 2006). In placebo controlled trials, the medication response rate was 48% and the remission rate 33%, compared to a response rate of 62% and remission rate of 43% in the comparator trials (p < .05). The effect size for the comparison of response rate to medications in the comparator and placebo controlled trials was large (Cohen’s d = 1.2).They only looked at trials of old age patients, but the same probably applies to everyone else.
Blinding patients in the placebo and fluoxetine alone groups but not in the CBT alone group (participants knew they would not be receiving fluoxetine) and the fluoxetine combined with CBT group (participants knew that they would be receiving fluoxetine) may have interacted with expectancy effects regarding improvement and acceptability of treatment assignment.
An unexpected gem from last year's Journal of the American Psychoanalytic Association: Mind over medicine.Our group at Columbia has completed preliminary work involving metaanalyses of randomized controlled trials comparing antidepressant medications to a placebo or active comparator in geriatric outpatients with Major Depressive Disorder (Sneed et al. 2006). In placebo controlled trials, the medication response rate was 48% and the remission rate 33%, compared to a response rate of 62% and remission rate of 43% in the comparator trials (p < .05). The effect size for the comparison of response rate to medications in the comparator and placebo controlled trials was large (Cohen’s d = 1.2).They only looked at trials of old age patients, but the same probably applies to everyone else.
Blinding patients in the placebo and fluoxetine alone groups but not in the CBT alone group (participants knew they would not be receiving fluoxetine) and the fluoxetine combined with CBT group (participants knew that they would be receiving fluoxetine) may have interacted with expectancy effects regarding improvement and acceptability of treatment assignment.

